These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16897993)

  • 21. Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706).
    Nakamura K; Tahara M; Kiyota N; Hayashi R; Akimoto T; Fukuda H; Fujii M; Boku N
    Jpn J Clin Oncol; 2009 Jul; 39(7):460-3. PubMed ID: 19429640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
    Ohashi T; Ohnishi M; Tanahashi S; Murai M
    Jpn J Clin Oncol; 2011 Mar; 41(3):348-52. PubMed ID: 21109512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Augmented antitumor efficacy of combination chemotherapy of nedaplatin with 5-fluorouracil in in vivo murine and human tumor model].
    Uchida N; Takeda Y; Kasai H; Hojo K; Wada T; Nishida K; Maekawa R; Sugita K; Yoshioka T
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2267-74. PubMed ID: 9881084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)].
    Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1151-8. PubMed ID: 9679577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I study of S-1 and nedaplatin for patients with recurrence of head and neck cancer.
    Kodaira T; Fuwa N; Tachibana H; Hidano S
    Anticancer Res; 2006; 26(3B):2265-8. PubMed ID: 16821599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined chemotherapy with low-dose cisplatin, tegafur and uracil for head and neck squamous cell carcinomas].
    Nishino H; Abe K; Ishikawa K; Kanazawa T; Tanaka H; Miyata M; Kitamura K; Morita M
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1617-21. PubMed ID: 10553420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H; Tsukuda M; Taguchi T
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combination chemotherapy with nedaplatin and 5-FU for head and neck cancer].
    Fujii M; Tokumaru Y; Imanishi Y; Kanke M; Kanzaki J; Ohno Y
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):53-8. PubMed ID: 9464329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
    Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamics of 5-fluorouracil combined with carboplatin in patients with head and neck cancer.
    Wihlm J; Leveque D; Klein T
    Anticancer Res; 1994; 14(6A):2395-6. PubMed ID: 7825979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between expression of vascular endothelial growth factor in tumor tissue from gastric cancers and chemotherapy effects: comparison between S-1 alone and the combination of S-1 plus CDDP.
    Boku N; Ohtsu A; Nagashima F; Shirao K; Koizumi W
    Jpn J Clin Oncol; 2007 Jul; 37(7):509-14. PubMed ID: 17673469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer.
    Ferrari D; Fiore J; Codecà C; Di Maria G; Bozzoni S; Bordin V; Caldiera S; Luciani A; Zonato S; Floriani I; Foa P
    Anticancer Drugs; 2009 Mar; 20(3):185-90. PubMed ID: 19396017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adjuvant chemotherapy with S-1 for advanced head and neck carcinoma].
    Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():172-8. PubMed ID: 16897997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combination chemotherapy with S-1 and cisplatin for non-small cell lung cancer].
    Wataya H; Ichinose Y
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():194-6. PubMed ID: 16898001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical development of S-1 (TS-1) for advanced gastric cancer].
    Wasaburo K; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Mihara S; Nakatani K; Nishimura K; Shimoda T; Azuma M; Katada C; Hanaoka N; Naruke A; Ryu T; Ishido K; Saigenji K
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():57-63. PubMed ID: 16897973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phase I study of concurrent radiotherapy with TS-1 and vitamin A (TAR Therapy) for head and neck cancer].
    Nakashima T; Kuratomi Y; Yamamoto T; Masuda M; Hirakawa N; Nakamura K; Shioyama Y; Umezaki T; Komune S
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):803-7. PubMed ID: 15984520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
    Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Late phase II study of S-1 in patients with advanced head and neck cancer].
    Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B;
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1381-90. PubMed ID: 11681245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Change of creatinine clearance rate in accordance with aging in Japanese patients with head and neck cancer].
    Nishimura G; Horiuchi C; Yoshida T; Kawakami M; Yabuki K; Taguchi T; Nagao J; Kondo N; Masuda Y; Matsuda H; Mikami Y; Tsukuda M
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):463-6. PubMed ID: 16612154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma.
    Kim HS; Kim HR; Kim GM; Kim HS; Koh YW; Kim SH; Choi EC; Hong YK; Sung JH; Kim SM; Kim JH; Cho BC
    Cancer Chemother Pharmacol; 2012 Oct; 70(4):539-46. PubMed ID: 22868340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.